The estrogen receptor (ER), progesterone receptor (PR), human epidermal growth factor receptor 2 (HER2) and Ki-67 are the most important biological markers for forming a prognosis and determining effective treatment methods for patients with breast cancer. This evidence concerns the gene MKI67 and breast cancer.